ARTICLES
Are Stimulants Overprescribed? Treatment of ADHD in Four U.S. Communities

https://doi.org/10.1097/00004583-199907000-00008Get rights and content

ABSTRACT

Objective

To address rising concerns about the possible overdiagnosis of attention-deficit hyperactivity disorder (ADHD) and overtreatment with stimulants. To date, almost no studies have examined ADHD in unbiased community-based studies, ascertaining both the prevalence of the diagnosis within nonreferred populations and the extent to which various treatments (i.e., stimulant medication, mental health treatments, and educational interventions) are used.

Method

As a part of the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study, the authors examined epidemiological survey data obtained from 1,285 children and their parents across 4 U.S. communities. Analyses examined the frequency of children's ADHD diagnosis, the extent to which medications were prescribed, as well as the provision of other services (e.g., psychosocial treatments, school-based educational interventions).

Results

Findings indicated that 5.1% of children met full DSM-III-R ADHD criteria across the pooled sample. Only 12.5% of children meeting ADHD criteria had been treated with stimulants during the previous 12 months. Some children who had been prescribed stimulants did not meet full ADHD diagnostic criteria, but these children manifested high levels of ADHD symptoms, suggesting that the medication had been appropriately prescribed. Children with ADHD were generally more likely to receive mental health counseling and/or school-based interventions than medication.

Conclusions

Medication treatments are often not used in treating ADHD children identified in the community, suggesting the need for better education of parents, physicians, and mental health professionals about the effectiveness of these treatments. On the basis of these data it cannot be concluded that substantial “overtreatment” with stimulants is occurring across communities in general.

REFERENCES (33)

  • HR Bird et al.

    Global measures of impairment for epidemiologic and clinical use with children and adolescents

    Int J Methods Psychiatr Res

    (1996)
  • JJ Bosco et al.

    Hyperkinesis: prevalence and treatment

  • L Copeland et al.

    Pediatricians' reported practices in the assessment and treatment of attention deficit disorders

    J Dev Behav Pediatr

    (1987)
  • SH Goodman et al.

    Measurement of risk for mental disorders and competence in a psychiatric epidemiologic community survey: the NIMH Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA)

    Soc Psychiatry Psychiatr Epidemiol

    (1998)
  • L Hancock

    Mother's little helper

    Newsweek

    (1996)
  • TP Ho et al.

    Establishing the constructs of childhood behavioral disturbances in a Chinese population: a questionnaire study

    J Abnorm Child Psychol

    (1996)
  • Cited by (271)

    • Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: A systematic review and meta-analysis

      2021, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      Thus, we conservatively assumed this figure (70 %) as the one reflecting the proportion of the children and adolescents with properly diagnosed ADHD who might unequivocally benefit from a trial with ADHD medication. It is important to highlight that we could not exclude from our analysis several groups that might be using stimulants adequately but are otherwise included in the group of non-affected individuals treated with ADHD medication, such as: a) previously diagnosed patients who responded to treatment and did not present anymore full ADHD diagnostic criteria when assessed in the studies (Jensen et al., 1999); b) subthreshold cases of ADHD who might have impairment and treatment indication (Kirova et al., 2019); and c) individuals with other diagnoses that are also indications for stimulant use (e.g., narcolepsy or resistant depression) (Greenhill et al., 2002). Nonetheless, our findings support the presence of over/inadequate treatment in different countries, raising concerns on stimulant overuse/ misuse, as recently suggested by others (Faraone et al., 2019).

    • Child and adolescent psychopharmacology at the beginning of the 21st century

      2019, Clinical Research in Paediatric Psychopharmacology: A Practical Overview of the Ethical, Scientific, and Regulatory Aspects
    • Cognitive Behavioral Therapy for Adolescents with ADHD

      2014, Child and Adolescent Psychiatric Clinics of North America
      Citation Excerpt :

      This finding similarly highlights the need for an effective psychosocial intervention. The relative lack of psychosocial interventions for adolescents with ADHD is also puzzling given that parents of adolescents prefer psychosocial intervention to medication, yet are more likely to have access to medication.52–54 Furthermore, parent satisfaction ratings are higher when parents received psychosocial treatment than when they received medication alone,55 suggesting that despite the lack of research attention, psychosocial treatments may have a place in the treatment of adolescent ADHD.

    View all citing articles on Scopus

    Reviewed under and accepted by Michael S. Jellinek, M.D., Associate Editor.

    View full text